Ocular Surface Parameters in Glaucoma Patients Treated with Topical Prostaglandin Analogs and the Importance of Switching to Preservative-Free Eye Drops-A Systematic Review.

Jaromir Wasyluk^1,2, Grzegorz Rotuski¹, Marta Dubisz^1,2, Radosław Różycki^1,3

¹Military Institute of Aviation Medicine, 01-755 Warsaw, Poland.

²OPTIMUM Bracka 11/13, Medical Center in Warsaw, 00-501 Warsaw, Poland.

³ORBITA Mińska 25a/lok.U10, Medical Center in Warsaw, 03-808 Warsaw, Poland.

PubMed PMC DOI PDF

Abstract

Background: The use of preservative agents in eye drop solutions may worsen symptoms of ocular surface disease, which is a highly prevalent syndrome worldwide. Preservatives are often used in pharmacotherapy of glaucoma, another disease concerning tens of millions of people around the globe. These numbers are predicted by the World Health Organization and are predicted to increase with time due to…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.